Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Brain energy failure in dementia syndromes: opportunities and challenges for glucagon-like peptide-1 receptor agonists
M., Prudhomme, D., Blanchet, R., & Giroux, I
Zhang et al., 2010
Wegovy and Ozempic are both semaglutide but at different doses
Why this trial matters: First bispecific + CD38 combo to show superior PFS and OS in Phase III in RRMM Potential new standard of care as early as second-line Demonstrates deep responses, high MRD-negativity, and durable outcomes First-line Strategies in BRAF V600E-Mutant mCRC: Real-World Evidence Signals Treatment Priorities In a real-world retrospective cohort of patients with BRAF V600E-mutant metastatic colorectal cancer (mCRC), frontline chemotherapy plus anti-VEGF therapy was associated with the longest survival outcomes, while BRAF-targeted strategies showed promising response rates, emphasizing the need for tailored therapy and prospective validation
US$ 21.23
US$ 25.62
US$ 28.58
US$ 27.39
US$ 25.77
US$ 22.78
US$ 21.44
